September 30, 2022
Loading...
You are here:  Home  >  Banking & Finance  >  Tri-County Public Companies  >  Earnings  >  Current Article

Atara ramps up research spending and net losses soar

IN THIS ARTICLE

Thousand Oaks biotech Atara Biotherapeutics reported a 71 percent increase in research and development spending for its first quarter, sending its net losses soaring nearly 60 percent to $66 million. The news drove shares down more than 20 percent to $27.01 as of 11 a.m. March 9, though net losses of $1.44 per share came…

Subscribe

    This article is only available to Business Times subscribers
  • Subscribers: or REGISTER for complete digital access.
  • Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
  • Check the STATUS of your Subscription Account.